CURE SYNGAP1 Chief Scientific Officer
MedSci Director
Kathryn Helde, PhD, lives in Seattle, WA and is the parent of three young men, including one living with SYNGAP1-related disorders. Kathryn graduated from Princeton University (Molecular Biology) in 1988. She studied developmental biology and genetics for her graduate research at the University of Utah (Human Genetics, 1995), her postdoctoral fellowship at the University of Washington (Pharmacology, 1995-1999), and as a research scientist at Fred Hutchinson Cancer Research Center.
Kathryn is passionate about understanding the molecular basis of SYNGAP1-related disorders and how to effectively treat it. Kathryn has volunteered with CURE SYNGAP1 (FKA SynGAP Research Fund) behind the scenes for 4 years, and comes to the CSO position excited to help CURE SYNGAP1 advance great ideas into reliable, safe, available, meaningful treatments for SYNGAP1-related disorders.
Kathryn is a parent coach, enjoys teaching genetics and quilting, and has mastered making homemade sweet pickles and Norwegian Christmas bread (Julekakke).
View press release announcing Kathryn as CURE SYNGAP1’s CSO here.
Listen to Kathryn on SYNGAP1 Stories Podcast here.
Email: cso@cureSYNGAP1.org